key: cord-0969002-2feiaasm
authors: Vidovich, Mladen I.
title: Transient Brugada-like ECG pattern in a patient with Coronavirus Disease 2019 (COVID-19)
date: 2020-04-16
journal: JACC. Case reports
DOI: 10.1016/j.jaccas.2020.04.007
sha: 30e6e7f896c3e9bfad348a7a66c22dfcc50e205c
doc_id: 969002
cord_uid: 2feiaasm

nan

A 61-year-old Hispanic male presented to the Emergency Department with a 5-day history of shortness of breath and substernal chest pain. He had felt febrile and generally ill over the past few days but had not taken his temperature. Upon presentation, he was febrile (38.5 C), hypertensive (156/81 mmHg), tachycardic (121 beats/min) and tachypneic (28 breaths/min).

His past medical history was significant for hepatitis C, dermatitis and obesity. The patient did not report history of syncope and there was family history of sudden cardiac death.

Laboratory data demonstrated mild hyponatremia (132 mmol/L), potassium (4.0 mmol/L) and magnesium (2.5 mmol/L) in the normal range and mild hypocalcemia (8.3 mmol/L). The Creactive protein was 150.7 mg/L and brain natriuretic peptide 19 pg/mL. The remainder of the laboratory values were unremarkable, and the troponin level was normal. His medications included clobetasol and triamcinolone ointments. The portable chest x-ray showed multifocal bilateral interstitial and airspace opacities with a normal cardiac silhouette (Figure 1) .

The electrocardiogram showed a Brugada-type pattern in right precordial leads with no reciprocal changes (Figure 2) . A bedside echocardiogram demonstrated mildly depressed global ejection fraction. Based on the clinical constellation of symptoms along with reduced ejection fraction and ST elevation we proceeded with emergency coronary angiography.

Diagnostic coronary angiography performed via right radial approach revealed angiographically normal coronaries (Figures 3 and 4) . Ventriculography confirmed the globally mildly reduced ejection fraction.

The patient was admitted to a dedicated COVID-19 intensive care unit. The COVID-19 results became available within 24 hours and were positive. His condition continued to improve, and he required minimal supplemental oxygen to maintain arterial saturation. All serial troponins values were negative. Two days later he developed a brief episode of supraventricular tachycardia that was successfully terminated with intravenous adenosine (Figure 5) .

Four days after the initial presentation, he was doing well without fever. The CRP had decreased to 25.4 mg/L and the ECG demonstrated near complete resolution of the initial Brugada-like ECG pattern (Figure 6) . The patient was discharged to home after the one-week hospital stay. Our case is important as it demonstrates the need to differentiate between the Brugada syndrome and the Brugada-like ECG morphology. Given that our patient had COVID-19associated Brugada electrocardiographic pattern with no history of syncope, observation therapy was recommended as the risk of major adverse cardiac events is low (6). 

Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong

Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic

Brugada phenocopy: new terminology and proposed classification

High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia

COVID-19 Infection Unmasking Brugada Syndrome

AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society